Arkolith/Insider Trading/LENZ/Form 4

Versant Vantage II GP-GP, LLC

10% OwnerLENZ Therapeutics, Inc. (LENZ) · full profile →Form 4 · filed Oct 2, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$10.4M
Net Open-Market Flow
-$10.4M
Transactions
6
6 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 30, 2025Sell(S)34K$45.35$1.6M822K
Sep 30, 2025Sell(S)50K$45.35$2.3M1.1M
Sep 30, 2025Sell(S)83K$46.41$3.9M1.1M
Sep 30, 2025Sell(S)58K$46.41$2.7M764K
Sep 30, 2025Sell(S)177$47.01$8K1.1M
Sep 30, 2025Sell(S)123$47.01$6K764K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-228493) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML